Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid injection versus TECAR therapy for frozen shoulder
IRCT20260906070929N2Phase 2Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of triamcinolone acetonide in adhesive capsulitis (AC) (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Shoulder internal rotation range of motion, Shoulder external rotation range of motion and 3 more. Started Oct 2026; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on IRCT20260906070929N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260906070929N2.